Last Updated on October 15, 2024 by The Health Master
Glenmark Pharmaceuticals Limited has received final approval from United States Food & Drug Administration (USFDA) for clindamycin phosphate gel USP, 1%, the generic version of Cleocin T gel, 1%, of Pharmacia & Upjohn.
According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T gel, 1% market achieved annual sales of approximately $73.8 million.
Glenmark’s current portfolio consists of 169 products authorized for distribution in the US marketplace and 42 ANDA’s pending approval with the USFDA.
In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
